RAP1 is a small, RAS-like GTPase that is activated by several extracellular stimuli via at least three different second messengers, namely diacylglycerol, calcium and cyclic AMP. In contrast to our knowledge about the function of RAS, only little is known about the function of RAP1. RAP1 was first identified as a suppressor of RAS-induced transformation, a feature of overexpressed RAP1 which is a result of interference with RAS-signaling pathways. However, recently we showed that activation of endogenous RAP1 does not interfere with RAS signaling (Zwartkruis et al., (1998) EMBO J. 17, 5905). To obtain insight into the biological function(s) of RAP1, we study the role of RAP1 and its guanine-nucleotide-exchange factors (RAPGEFs) in C. elegans . The genome sequencing project has revealed the existence of two RAP genes, which are the putative homologues of mammalian
rap-1 and
rap-2 . In addition, four putative homologues of mammalian RAPGEFs were found: the C. elegans
c3g , a calcium- and diacylglycerol-inducible GEF ( caldaggef ), the cAMP-inducible GEF ( epac ) (de Rooij et al., (1998) Nature 396, 474) and a PDZ-containing GEF ( pdz-gef ) (de Rooij et al., manuscript in prep.). The specificity of these putative RAPGEFs for RAP1 will be determined in vitro. We are currently investigating the expression patterns of these genes using GFP gene fusions. In addition, we are screening for loss-of-function mutants in a chemically mutagenized library and are determining the effect of overexpression and constitutively active variants on transgenic worms. Via this approach we hope to obtain insight into the physiological role of RAP1 signaling in C. elegans .